Compositions and methods of using compositions for treatment of inflammatory diseases and immune disorders are provided. Allylamino compounds are disclosed which are inhibitors of semicarbazide-sensitive amine oxidase (SSAO) and/or vascular adhesion protein 1 (VAP-1). The compounds have therapeutic utility in suppressing inflammation and inflammatory responses, and in treatment of several disorders, including multiple sclerosis and stroke.
提供了用于治疗炎症性疾病和免疫紊乱的组合物及使用组合物的方法。公开了一种
烯丙胺化合物,它们是半胱
氨酸敏感胺
氧化酶(S
SAO)和/或血管粘附蛋白1(VA
P-1)的
抑制剂。这些化合物在抑制炎症和炎症反应方面具有治疗效用,并可用于治疗多发性硬化症和中风等多种疾病。